Sanofi India Ltd

Sanofi India Ltd company information, Employees & Contact Information

Explore related pages

Related company profiles:

External link for Sanofi India Ltd
Looking for a particular Sanofi India Ltd employee's phone or email?

Sanofi India Ltd Questions

News

Digital Transformation and Artificial Intelligence - Sanofi

Digital Transformation and Artificial Intelligence Sanofi

Sanofi: Information concerning the total number of voting rights and shares - July 2025 - GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - July 2025 GlobeNewswire

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation - Yahoo Finance

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation Yahoo Finance

Our Responsible Business Values & Ethics - Sanofi

Our Responsible Business Values & Ethics Sanofi

Press release: Online availability of Sanofi’s half-year financial report for 2025 - GlobeNewswire

Press release: Online availability of Sanofi’s half-year financial report for 2025 GlobeNewswire

Press Release: Sanofi announces extension of Blueprint tender offer - Yahoo Finance

Press Release: Sanofi announces extension of Blueprint tender offer Yahoo Finance

Respiratory Syncytial Virus (RSV) - Sanofi

Respiratory Syncytial Virus (RSV) Sanofi

Press release: Availability of the Q3 2025 Aide mémoire - GlobeNewswire

Press release: Availability of the Q3 2025 Aide mémoire GlobeNewswire

Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 - Yahoo Finance

Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Yahoo Finance

Environmental Impact and Healthcare Systems’ Resilience - Sanofi

Environmental Impact and Healthcare Systems’ Resilience Sanofi

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. - GlobeNewswire

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. GlobeNewswire

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease - Yahoo Finance

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Yahoo Finance

Sustainability: Building a Healthier World - Sanofi

Sustainability: Building a Healthier World Sanofi

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia - GlobeNewswire

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia GlobeNewswire

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis - Yahoo Finance

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Yahoo Finance

Global Health Unit: Expanding Healthcare Access - Sanofi

Global Health Unit: Expanding Healthcare Access Sanofi

Our DE&I Board: Leading Diversity - Sanofi

Our DE&I Board: Leading Diversity Sanofi

Press release: Sanofi successfully prices €1.5 billion bond issue - GlobeNewswire

Press release: Sanofi successfully prices €1.5 billion bond issue GlobeNewswire

Information on Dengvaxia® (Dengue tetravalent vaccine) - Sanofi

Information on Dengvaxia® (Dengue tetravalent vaccine) Sanofi

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season - Yahoo Finance

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Yahoo Finance

Press Release: Sanofi completes acquisition of DR-0201 - GlobeNewswire

Press Release: Sanofi completes acquisition of DR-0201 GlobeNewswire

Press Release: Sanofi to acquire Blueprint Medicines, - GlobeNewswire

Press Release: Sanofi to acquire Blueprint Medicines, GlobeNewswire

Our Global Manufacturing & Supply Network - Sanofi

Our Global Manufacturing & Supply Network Sanofi

Our Science - Sanofi

Our Science Sanofi

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US - Yahoo Finance

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US Yahoo Finance

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease - Yahoo Finance

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease Yahoo Finance

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose - Yahoo Finance

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose Yahoo Finance

A Legacy of Impact - Sanofi

A Legacy of Impact Sanofi

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study - Yahoo Finance

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study Yahoo Finance

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia - Yahoo Finance

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Yahoo Finance

Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts - Yahoo Finance

Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts Yahoo Finance

Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion - Yahoo Finance

Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion Yahoo Finance

Press Release: Sanofi’s SAR402663 earns fast track - GlobeNewswire

Press Release: Sanofi’s SAR402663 earns fast track GlobeNewswire

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline - GlobeNewswire

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline GlobeNewswire

Share, Structure and Voting Rights - Sanofi

Share, Structure and Voting Rights Sanofi

Press Release: Sanofi completes acquisition of Blueprint Medicines - GlobeNewswire

Press Release: Sanofi completes acquisition of Blueprint Medicines GlobeNewswire

Press Release: Sanofi’s SAR446597 earns fast track - GlobeNewswire

Press Release: Sanofi’s SAR446597 earns fast track GlobeNewswire

Press Release: Opella reaches study milestone for Cialis - Yahoo Finance

Press Release: Opella reaches study milestone for Cialis Yahoo Finance

Press Release: Sanofi’s Sarclisa approved in the EU for the - GlobeNewswire

Press Release: Sanofi’s Sarclisa approved in the EU for the GlobeNewswire

mRNA Technology: Vaccines and Beyond - Sanofi

mRNA Technology: Vaccines and Beyond Sanofi

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader - GlobeNewswire

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader GlobeNewswire

Press Release: Sanofi to acquire Dren Bio’s bispecific - GlobeNewswire

Press Release: Sanofi to acquire Dren Bio’s bispecific GlobeNewswire

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., - GlobeNewswire

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., GlobeNewswire

Sanofi's New $1M Community Health Fund Targets 14 Mass. Organizations to Transform Healthcare Access - Stock Titan

Sanofi's New $1M Community Health Fund Targets 14 Mass. Organizations to Transform Healthcare Access Stock Titan

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare - GlobeNewswire

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare GlobeNewswire

Press Release: Sanofi’s respiratory pipeline advances with - GlobeNewswire

Press Release: Sanofi’s respiratory pipeline advances with GlobeNewswire

Interested in partnering with Sanofi Pasteur? - Nature

Interested in partnering with Sanofi Pasteur? Nature

Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact - PR Newswire Canada

Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact PR Newswire Canada

Sanofi India Share Price Today - Sanofi India Stock Price Live NSE/BSE - ICICI Direct

Sanofi India Share Price Today - Sanofi India Stock Price Live NSE/BSE ICICI Direct

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery - MultiVu

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery MultiVu

Sanofi receives marketing approval for its diabetes drug Soliqua™ in India - Passionate In Marketing

Sanofi receives marketing approval for its diabetes drug Soliqua™ in India Passionate In Marketing

Top Sanofi India Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant